85 related articles for article (PubMed ID: 9792469)
1. Management and outcome of severe diabetic foot infections.
Diamantopoulos EJ; Haritos D; Yfandi G; Grigoriadou M; Margariti G; Paniara O; Raptis SA
Exp Clin Endocrinol Diabetes; 1998; 106(4):346-52. PubMed ID: 9792469
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
Petrakis IE; Sciacca V
Int Surg; 1999; 84(2):122-8. PubMed ID: 10408282
[TBL] [Abstract][Full Text] [Related]
3. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
Claeys LG; Horsch S
Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones.
Lobmann R; Ambrosch A; Seewald M; Dietlein M; Zink K; Kullmann KH; Lehnert H
Diabetes Nutr Metab; 2004 Jun; 17(3):156-62. PubMed ID: 15334793
[TBL] [Abstract][Full Text] [Related]
5. Conservative management of osteomyelitis in the feet of diabetic patients.
Venkatesan P; Lawn S; Macfarlane RM; Fletcher EM; Finch RG; Jeffcoate WJ
Diabet Med; 1997 Jun; 14(6):487-90. PubMed ID: 9212316
[TBL] [Abstract][Full Text] [Related]
6. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
Browne AC; Vearncombe M; Sibbald RG
Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers.
Kästenbauer T; Hörnlein B; Sokol G; Irsigler K
Diabetologia; 2003 Jan; 46(1):27-30. PubMed ID: 12637979
[TBL] [Abstract][Full Text] [Related]
8. Oral clindamycin and ciprofloxacin therapy for diabetic foot infections.
Sesin GP; Paszko A; O'Keefe E
Pharmacotherapy; 1990; 10(2):154-6. PubMed ID: 2190194
[TBL] [Abstract][Full Text] [Related]
9. Combined primary subintimal and endoluminal angioplasty for ischaemic inferior-limb ulcers in diabetic patients: 5-year practice in a multidisciplinary 'diabetic-foot' service.
Alexandrescu V; Hubermont G; Philips Y; Guillaumie B; Ngongang Ch; Coessens V; Vandenbossche P; Coulon M; Ledent G; Donnay JC
Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):448-56. PubMed ID: 19213580
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
[TBL] [Abstract][Full Text] [Related]
11. Diabetic foot infection.
Bader MS
Am Fam Physician; 2008 Jul; 78(1):71-9. PubMed ID: 18649613
[TBL] [Abstract][Full Text] [Related]
12. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
[TBL] [Abstract][Full Text] [Related]
13. [Amoxicillin/clavulanic acid in therapy of bacterial infections of the diabetic foot. Results of an observational study].
Gerards V; Schiewe U; Gerards HH; Machka K; Höbel W; Meister W
MMW Fortschr Med; 2000 Jan; 142(3 Suppl):187-94. PubMed ID: 10783611
[TBL] [Abstract][Full Text] [Related]
14. Update in diagnosis and treatment of diabetic foot infections.
Miller AO; Henry M
Phys Med Rehabil Clin N Am; 2009 Nov; 20(4):611-25. PubMed ID: 19781502
[TBL] [Abstract][Full Text] [Related]
15. Effect of ciprofloxacin compared to gentamicin in the treatment of experimental intraabdominal infections in rats.
Lahnborg G; Nord CE
Scand J Infect Dis Suppl; 1989; 60():35-8. PubMed ID: 2756352
[TBL] [Abstract][Full Text] [Related]
16. [Long-term evaluation of chronic diabetic foot ulcers, non-healed after hyperbaric oxygen therapy].
Albuquerque E Sousa J
Rev Port Cir Cardiotorac Vasc; 2005; 12(4):227-37. PubMed ID: 16474863
[TBL] [Abstract][Full Text] [Related]
17. Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections?
de Vries MG; Ekkelenkamp MB; Peters EJ
Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):453-6. PubMed ID: 24220766
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Caldwell JW; Singh S; Johnson RH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
[TBL] [Abstract][Full Text] [Related]
19. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
[TBL] [Abstract][Full Text] [Related]
20. Clindamycin-resistant Streptococcus pyogenes: report of a case.
Walsh SR; Ferraro MJ; Durand ML
Diagn Microbiol Infect Dis; 2004 Jul; 49(3):223-5. PubMed ID: 15246514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
